Skip to main content

Weill Cornell Medicine

Grantee

Areas of Interest

Health and Life Sciences

Organization Type

Non-Profit

Region

New York City

Funding date

2020 - 2021

Mission

Medicine is constantly changing, but Weill Cornell Medicine's compassionate, superior patient care is constant. WCM's mission is shaped by three parts: Exceptional care, research and education. Weill Cornell Medicine is among the nation's top-ranked medical and graduate schools, striving for excellence in its education of the world's future healthcare leaders. Research by faculty and graduate students at Weill Cornell Medicine is collaborative, groundbreaking and patient-focused.

Our support

The Pershing Square Foundation allocated funding towards COVID-19 research undertaken by the institutions associated with its talented PSSCRA community. We sought our scientific advisors’ knowledge and expertise to solicit proposals from researchers at their respective institutions whose work they deemed exceptional and could not only make an impact on the SARS-CoV-2 virus, but also other diseases. Our hope is that the synergy amongst cancer research, immunotherapy, genetics, and epigenetics might shed new light on COVID research, expand our basic scientific knowledge, and strengthen our arsenal for current and future health crises. This funding to Weill Cornell Medicine went to Dr. Christopher Mason to support his project “TINY COVID: Rapid, Mobile, and Point-of-care Diagnostics for SARS-CoV-2 from Saliva” and Drs. John Blenis and Lewis Cantley to support their project, “Targeting cellular protein kinases as treatment for COVID-19.”